These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18480355)

  • 21. Use of triple-site ventricular pacing in a patient with severe congestive heart failure and atrial fibrillation.
    Osman F; Jeilan M; Ng GA
    Pacing Clin Electrophysiol; 2009 May; 32(5):673-4. PubMed ID: 19422592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-wave alternans in the sudden cardiac death in heart failure trial population: signal or noise?
    Rosenbaum DS
    Circulation; 2008 Nov; 118(20):2015-8. PubMed ID: 19001031
    [No Abstract]   [Full Text] [Related]  

  • 23. [Arrhythmia].
    Kimura E
    Naika; 1970 Jun; 25(6):1067-70. PubMed ID: 5431236
    [No Abstract]   [Full Text] [Related]  

  • 24. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children.
    Rosenthal D; Chrisant MR; Edens E; Mahony L; Canter C; Colan S; Dubin A; Lamour J; Ross R; Shaddy R; Addonizio L; Beerman L; Berger S; Bernstein D; Blume E; Boucek M; Checchia P; Dipchand A; Drummond-Webb J; Fricker J; Friedman R; Hallowell S; Jaquiss R; Mital S; Pahl E; Pearce FB; Rhodes L; Rotondo K; Rusconi P; Scheel J; Pal Singh T; Towbin J
    J Heart Lung Transplant; 2004 Dec; 23(12):1313-33. PubMed ID: 15607659
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough?
    Curtis AB
    J Am Coll Cardiol; 2008 Aug; 52(7):557-8. PubMed ID: 18687250
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arrhythmia surgery in patients with and without congenital heart disease.
    Mavroudis C; Deal BJ; Backer CL; Tsao S
    Ann Thorac Surg; 2008 Sep; 86(3):857-68; discussion 857-68. PubMed ID: 18721574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular arrhythmias in heart failure patients.
    Lo R; Hsia HH
    Cardiol Clin; 2008 Aug; 26(3):381-403, vi. PubMed ID: 18538186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely.
    Cleland JG; Tageldien A; Maarouf N; Hobson N
    Heart; 2008 Aug; 94(8):963-6. PubMed ID: 18625785
    [No Abstract]   [Full Text] [Related]  

  • 31. Overdrive pacing suppresses ectopy and minimizes left ventricular assist device suction events.
    Ambardekar AV; Lowes B; Cleveland JC; Brieke A
    Circ Heart Fail; 2009 Sep; 2(5):516-7. PubMed ID: 19808384
    [No Abstract]   [Full Text] [Related]  

  • 32. Is it time to expand the use of cardiac resynchronization therapy to patients with mildly symptomatic heart failure?
    Exner DV
    J Am Coll Cardiol; 2009 Nov; 54(20):1847-9. PubMed ID: 19800192
    [No Abstract]   [Full Text] [Related]  

  • 33. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic action and blood levels of quinidine during its use in therapy of arrhythmia caused by auricular fibrillation and fibrillo-fluctuation].
    DI PAOLO E; VANCINI B
    G Clin Med; 1958 May; 39(5):761-85. PubMed ID: 13574545
    [No Abstract]   [Full Text] [Related]  

  • 35. Use and misuse of surrogate outcomes in arrhythmia trials.
    Connolly SJ
    Circulation; 2006 Feb; 113(6):764-6. PubMed ID: 16476858
    [No Abstract]   [Full Text] [Related]  

  • 36. [Value of the clinical use of proscillaridin A].
    Ratti G; Rocca F; Savastano A
    Clin Ter; 1966 Sep; 38(5):413-24. PubMed ID: 5993561
    [No Abstract]   [Full Text] [Related]  

  • 37. [Indications for automatic implantable ventricular defibrillators. French version. Bureau of Heart Rhythm Group of the French Cardiology Society].
    Arch Mal Coeur Vaiss; 2000 Oct; 93(10):1227-32. PubMed ID: 11107482
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of ventricular arrhythmias.
    Aronow WS
    Compr Ther; 2008; 34(2):89-99. PubMed ID: 18833785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 'Happy Ending Problem' of cardiac pacing? Cardiac resynchronization therapy for patients with atrial fibrillation and heart failure after atrioventricular junction ablation.
    Szili-Torok T; Mihalcz A; Jordaens L
    Europace; 2008 Jul; 10(7):779-81. PubMed ID: 18515788
    [No Abstract]   [Full Text] [Related]  

  • 40. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.